Emory University is a leading research university that fosters excellence and attracts world-class talent to innovate today and prepare leaders for the future. We welcome candidates who can contribute to the diversity and excellence of our academic community.

This fellowship is an intensive one-year program, July 1, 2021-June 30, 2022, for physicians who have completed a hematology or hematology/oncology fellowship and wish to have advanced training in the management of patients with hemostatic and thrombotic disorders. The goal of the training is to prepare fellows for a career that will include care of patients with congenital bleeding disorders. Fellows, as an Instructor, will have clinical responsibilities (inpatient and outpatient), dedicated research time, and mentorship to allow for professional development. Fellows will complete eight weeks as the attending physician on the hematology consultation service at Emory University Hospitals. Fellows will be paired with faculty mentors to provide guidance and directed learning. When not on the consultation service, fellows will have 1-1.5 days of clinic per week including the multidisciplinary comprehensive bleeding disorders clinic. The aim and expectation of the fellowship is for the fellow to acquire and manage patients with a variety of hemostatic and thrombotic disorders. Fellows will also design and complete a research project in their chosen area, and will participate in education of our Hematology/Oncology fellows and other trainees.

Curriculum

• Understand normal hemostasis.
• Understand the pathophysiology of congenital and acquired bleeding disorders and how this translates into diagnosis and management.
• Manage acute bleeding events in patients with hemophilia, hemophilia with inhibitor, von Willebrand disease, platelet function defects, fibrinolytic defects, and acquired coagulation disorders secondary to coagulation factor inhibitors, von Willebrand factor inhibitors, and anticoagulants.
• Develop treatment plans to reduce complications of congenital bleeding disorders (hemophilia, hemophilia with inhibitor, Von Willebrand disease, platelet function defects, etc).
• Manage patients with congenital bleeding disorders (hemophilia, hemophilia with inhibitor, von Willebrand disease, platelet function defects, etc.) during invasive and surgical procedures to reduce bleeding complications.
• Work with the multidisciplinary team to manage complications of congenital bleeding disorders, including but not limited to inhibitors, arthropathy, heavy menstrual bleeding, and pain.
• Understand the role that point-of-care ultrasound plays in evaluation of acute and chronic joint pain.
• Evaluate patients with thrombosis for thrombophilia, duration of anticoagulation, and complications of thrombotic disease
• Manage complications of thrombotic disease and anticoagulation
• Understand the role of laboratory testing in the management of patients with thrombosis
• Develop and implement strategies to reduce complications of pregnancy related hemostatic and thrombotic disorders

Applicants must have completed an accredited fellowship in Hematology/Oncology or Hematology, have passed the certifying examination of the American Board of Internal Medicine, and qualify to take the Hematology subspecialty examination of the American Board of Internal Medicine by the start date of the Fellowship. Applicants must also be eligible for licensure as a physician in the state of Georgia and qualify for a DEA license.

Please include the following with your application:

• An updated CV
• A personal statement of intent describing your reasons for pursuing the Fellowship as well as your career goals and plans, and how these may be enhanced by the Fellowship
• At least 3 references from your Hematology/Oncology Fellowship training program. Please include mailing address, telephone number and email address.

Emory University is a leading research university that fosters excellence and attracts world-class talent to innovate today and prepare leaders for the future. We welcome candidates who can contribute to the diversity and excellence of our academic community.

Emory University is an equal employment opportunity and affirmative action employer. Women, minorities, people with disabilities and veterans are strongly encouraged to apply.

Emory University is dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, gender, genetic information, age, disability, sexual orientation, gender identity, gender expression, and veteran's status. Emory University does not discriminate in admissions, educational programs, or employment on the basis of any factor stated above or prohibited under applicable law. Students, faculty, and staff are assured of participation in University programs and in the use of facilities without such discrimination. Emory University complies with Executive Order 11246, as amended, Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veteran's Readjustment Assistance Act, and applicable executive orders, federal and state regulations regarding nondiscrimination, equal opportunity and affirmative action. Emory University is committed to achieving a diverse workforce through application of its affirmative action, equal opportunity and nondiscrimination policy in all aspects of employment including recruitment, hiring, promotions, transfers, discipline, terminations, wage and salary administration, benefits, and training. Inquiries regarding this policy should be directed to the Emory University Department of Equity and Inclusion, 201 Dowman Drive, Administration Building, Atlanta, GA 30322. Telephone: 404-727-9867 (V) | 404-712-2049 (TDD).
Emory University is committed to providing reasonable accommodations to qualified individuals with disabilities upon request. To request this document in an alternate format or to request a reasonable accommodation, please contact the Department of Accessibility Services at 404-727-9877 (V) | 404-712-2049 (TDD). Please note that one week advance notice is preferred.